{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:37:57Z","timestamp":1782351477077,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/ijo.2016.223","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T08:41:57Z","timestamp":1480927317000},"page":"262-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls"],"prefix":"10.1038","volume":"41","author":[{"given":"S","family":"Heeb\u00f8ll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M K","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Ornstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T N","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S B","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,5]]},"reference":[{"key":"BFijo2016223_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766\u2013781.","journal-title":"Lancet"},{"key":"BFijo2016223_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1381\/096089204323093408","volume":"14","author":"CC Mottin","year":"2004","unstructured":"Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004; 14: 635\u2013637.","journal-title":"Obes Surg"},{"key":"BFijo2016223_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jpeds.2012.08.043","volume":"162","author":"JA Welsh","year":"2013","unstructured":"Welsh JA, Karpen S, Vos MB . Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr 2013; 162: 496\u2013500 e1.","journal-title":"J Pediatr"},{"key":"BFijo2016223_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM . Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274\u2013285.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFijo2016223_CR5","doi-asserted-by":"publisher","first-page":"134351","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ . Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 134351.","journal-title":"J Clin Invest"},{"key":"BFijo2016223_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/13813455.2010.543136","volume":"117","author":"DP Koonen","year":"2011","unstructured":"Koonen DP, Jensen MK, Handberg A . Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome? Arch Physiol Biochem 2011; 117: 57\u201363.","journal-title":"Arch Physiol Biochem"},{"key":"BFijo2016223_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2010.222844","volume":"60","author":"ME Miquilena-Colina","year":"2011","unstructured":"Miquilena-Colina ME, Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, Fernandez-Bermejo M, Lozano-Rodriguez T et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 2011; 60: 1394\u20131402.","journal-title":"Gut"},{"key":"BFijo2016223_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/eci.12192","volume":"44","author":"C Garcia-Monzon","year":"2014","unstructured":"Garcia-Monzon C, Lo Iacono O, Crespo J, Romero-Gomez M, Garcia-Samaniego J, Fernandez-Bermejo M et al. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. Eur J Clin Invest 2014; 44: 65\u201373.","journal-title":"Eur J Clin Invest"},{"key":"BFijo2016223_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2796.2011.02442.x","volume":"271","author":"A Handberg","year":"2012","unstructured":"Handberg A, H\u00f8jlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J et al. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med 2012; 271: 294\u2013304.","journal-title":"J Intern Med"},{"key":"BFijo2016223_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","volume":"51","author":"S Heeb\u00f8ll","year":"2016","unstructured":"Heeb\u00f8ll S, Kreuzfeldt M, Hamilton-Dutoit S, Kj\u00e6r Poulsen M, St\u00f8dkilde-J\u00f8rgensen H, M\u00f8ller HJ et al. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. Scand J Gastroenterol 2016; 51: 456\u2013464.","journal-title":"Scand J Gastroenterol"},{"key":"BFijo2016223_CR11","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1210\/jc.2014-2799","volume":"99","author":"MJ Ornstrup","year":"2014","unstructured":"Ornstrup MJ, Harsl\u00f8f T, Kj\u00e6r TN, Langdahl BL, Pedersen SB . Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab 2014; 99: 4720\u20134729.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2016223_CR12","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1210\/jc.2015-3476","volume":"101","author":"MK Poulsen","year":"2016","unstructured":"Poulsen MK, Nellemann B, St\u00f8dkilde-J\u00f8rgensen H, Pedersen SB, Gr\u00f8nb\u00e6k H, Nielsen S . Impaired insulin suppression of VLDL-triglyceride kinetics in non-alcoholic fatty liver disease. J Clin Endocrinol Metab 2016; 101: 1637\u20131646.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2016223_CR13","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462\u2013E468.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2016223_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1530\/EJE-14-0792","volume":"172","author":"MJ Ornstrup","year":"2015","unstructured":"Ornstrup MJ, Kj\u00e6r TN, Harsl\u00f8f T, St\u00f8dkilde-J\u00f8rgensen H, Hougaard DM, Cohen A et al. Adipose tissue, estradiol levels, and bone health in obese men with metabolic syndrome. Eur J Endocrinol 2015; 172: 205\u2013216.","journal-title":"Eur J Endocrinol"},{"key":"BFijo2016223_CR15","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR . Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487\u20131495.","journal-title":"Diabetes Care"},{"key":"BFijo2016223_CR16","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1161\/CIRCULATIONAHA.106.626135","volume":"114","author":"A Handberg","year":"2006","unstructured":"Handberg A, Levin K, Hojlund K, Beck-Nielsen H . Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. Circulation 2006; 114: 1169\u20131176.","journal-title":"Circulation"},{"key":"BFijo2016223_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313\u20131321.","journal-title":"Hepatology"},{"key":"BFijo2016223_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012; 56: 1751\u20131759.","journal-title":"Hepatology"},{"key":"BFijo2016223_CR19","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1073\/pnas.0904944106","volume":"106","author":"E Fabbrini","year":"2009","unstructured":"Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009; 106: 15430\u201315435.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFijo2016223_CR20","doi-asserted-by":"publisher","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","volume":"294","author":"D Greco","year":"2008","unstructured":"Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T et al. Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1281\u2013G1287.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFijo2016223_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1478-3231.2010.02248.x","volume":"30","author":"LP Bechmann","year":"2010","unstructured":"Bechmann LP, Gieseler RK, Sowa JP, Kahraman A, Erhard J, Wedemeyer I et al. Apoptosis is associated with CD36\/fatty acid translocase upregulation in non-alcoholic steatohepatitis. Liver Int 2010; 30: 850\u2013859.","journal-title":"Liver Int"},{"key":"BFijo2016223_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.18632\/aging.100652","volume":"6","author":"F Sheedfar","year":"2014","unstructured":"Sheedfar F, Sung MM, Aparicio-Vergara M, Kloosterhuis NJ, Miquilena-Colina ME, Vargas-Castrillon J et al. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. Aging 2014; 6: 281\u2013295.","journal-title":"Aging"},{"key":"BFijo2016223_CR23","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.ejrad.2009.03.062","volume":"74","author":"M Krssak","year":"2010","unstructured":"Krssak M, Hofer H, Wrba F, Meyerspeer M, Brehm A, Lohninger A et al. Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy. Eur J Radiol 2010; 74: e60\u2013e66.","journal-title":"Eur J Radiol"},{"key":"BFijo2016223_CR24","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1038\/nutd.2014.11","volume":"4","author":"L Kn\u00f8sgaard","year":"2014","unstructured":"Kn\u00f8sgaard L, Thomsen SB, Stockel M, Vestergaard H, Handberg A . Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals. Nutr Diabetes 2014; 4: e114.","journal-title":"Nutr Diabetes"},{"key":"BFijo2016223_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.freeradbiomed.2012.02.012","volume":"52","author":"R Liani","year":"2012","unstructured":"Liani R, Halvorsen B, Sestili S, Handberg A, Santilli F, Vazzana N et al. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radic Biol Med 2012; 52: 1318\u20131324.","journal-title":"Free Radic Biol Med"},{"key":"BFijo2016223_CR26","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1515\/cclm-2011-0950","volume":"50","author":"S Lykkeboe","year":"2012","unstructured":"Lykkeboe S, Larsen AL, Handberg A . Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasma. Clin Chem Lab Med 2012; 50: 1071\u20131074.","journal-title":"Clin Chem Lab Med"},{"key":"BFijo2016223_CR27","doi-asserted-by":"publisher","first-page":"e34378","DOI":"10.1371\/journal.pone.0034378","volume":"7","author":"V Bieghs","year":"2012","unstructured":"Bieghs V, Verheyen F, van Gorp PJ, Hendrikx T, Wouters K, Lutjohann D et al. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PloS One 2012; 7: e34378.","journal-title":"PloS One"},{"key":"BFijo2016223_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1053\/j.gastro.2010.02.051","volume":"138","author":"V Bieghs","year":"2010","unstructured":"Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, Binder CJ et al. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 2010; 138: 2477\u20132486 e1\u22123.","journal-title":"Gastroenterology"},{"key":"BFijo2016223_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1152\/physrev.00003.2009","volume":"90","author":"JF Glatz","year":"2010","unstructured":"Glatz JF, Luiken JJ, Bonen A . Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 2010; 90: 367\u2013417.","journal-title":"Physiol Rev"},{"key":"BFijo2016223_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1172\/JCI19528","volume":"113","author":"CP Liang","year":"2004","unstructured":"Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 2004; 113: 764\u2013773.","journal-title":"J Clin Invest"},{"key":"BFijo2016223_CR31","doi-asserted-by":"publisher","first-page":"19034","DOI":"10.1074\/jbc.M115.640292","volume":"290","author":"P Steneberg","year":"2015","unstructured":"Steneberg P, Sykaras AG, Backlund F, Straseviciene J, Soderstrom I, Edlund H . Hyperinsulinemia enhances hepatic expression of the fatty acid transporter Cd36 and provokes hepatosteatosis and hepatic insulin resistance. J Biol Chem 2015; 290: 19034\u201319043.","journal-title":"J Biol Chem"},{"key":"BFijo2016223_CR32","doi-asserted-by":"publisher","first-page":"E504","DOI":"10.1152\/ajpendo.00653.2011","volume":"303","author":"X Buque","year":"2012","unstructured":"Buque X, Cano A, Miquilena-Colina ME, Garcia-Monzon C, Ochoa B, Aspichueta P . High insulin levels are required for FAT\/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes. Am J Physiol Endocrinol Metab 2012; 303: E504\u2013E514.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2016223_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tcm.2003.09.004","volume":"14","author":"AC Nicholson","year":"2004","unstructured":"Nicholson AC . Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. Trends Cardiovasc Med 2004; 14: 8\u201312.","journal-title":"Trends Cardiovasc Med"},{"key":"BFijo2016223_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2337\/dc07-1424","volume":"31","author":"D Glintborg","year":"2008","unstructured":"Glintborg D, H\u00f8jlund K, Andersen M, Henriksen JE, Beck-Nielsen H, Handberg A . Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. Diabetes Care 2008; 31: 328\u2013334.","journal-title":"Diabetes Care"},{"key":"BFijo2016223_CR35","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1210\/jc.2009-2002","volume":"95","author":"A Handberg","year":"2010","unstructured":"Handberg A, Norberg M, Stenlund H, Hallmans G, Attermann J, Eriksson JW . Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk. J Clin Endocrinol Metab 2010; 95: 1939\u20131946.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2016223_CR36","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1538-7836.2011.04220.x","volume":"9","author":"MJ Alkhatatbeh","year":"2011","unstructured":"Alkhatatbeh MJ, Mhaidat NM, Enjeti AK, Lincz LF, Thorne RF . The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles. J Thromb Haemost 2011; 9: 844\u2013851.","journal-title":"J Thromb Haemost"},{"key":"BFijo2016223_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13293-015-0028-8","volume":"6","author":"CM Gustafson","year":"2015","unstructured":"Gustafson CM, Shepherd AJ, Miller VM, Jayachandran M . Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans. Biol Sex Differ 2015; 6: 10.","journal-title":"Biol Sex Differ"},{"key":"BFijo2016223_CR38","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1038\/nutd.2013.1","volume":"3","author":"MJ Alkhatatbeh","year":"2013","unstructured":"Alkhatatbeh MJ, Enjeti AK, Acharya S, Thorne RF, Lincz LF . The origin of circulating CD36 in type 2 diabetes. Nutr Diabetes 2013; 3: e59.","journal-title":"Nutr Diabetes"},{"key":"BFijo2016223_CR39","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1096\/fj.12-206862","volume":"26","author":"D Zhou","year":"2012","unstructured":"Zhou D, Samovski D, Okunade AL, Stahl PD, Abumrad NA, Su X . CD36 level and trafficking are determinants of lipolysis in adipocytes. FASEB J 2012; 26: 4733\u20134742.","journal-title":"FASEB J"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijo2016223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2016223","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2016223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T19:29:56Z","timestamp":1647372596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2016223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFijo2016223"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2016.223","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,5]]},"assertion":[{"value":"23 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}